snk01
nkgen
['snk01', 'sarcoma']
the natural killer (nk) cell therapy snk01 appears to be safe with some evidence of clinical activity when combined with checkpoint inhibitors (ci) in patients with advanced sarcomas, independent of pd-l1 status. #esmo22 
CGTLive™ delivers quality and relevant information to healthcare professionals on cell, gene, regenerative, and engineered medicines to ultimately improve care.